VJOncology is committed to improving our service to you

ESMO Breast 2020 | HER2 blockade in HER2-E induces low-proliferative luminal A phenotype

VJOncology is committed to improving our service to you

Aleix Prat

Aleix Prat, MD, PhD, Clinical and Provincial Hospital of Barcelona, Barcelona, Spain, discussed the phenotypic changes of HER2+ breast cancer during and after dual HER2 blockade. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter